Level Biotechnology (3118) — Free Cash Flow Generation Index
Level Biotechnology (3118) has a Free Cash Flow Generation Index of 0.62x as of September 2025. Free cash flow of NT$7.37 Million represents 1% of operating cash flow (NT$11.81 Million). Read 3118 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Level Biotechnology Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Level Biotechnology across 8 annual periods. Explore capital reinvestment ratio of Level Biotechnology to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Level Biotechnology (2017–2024)
Year-by-year Free Cash Flow Generation Index for Level Biotechnology. For the full company profile including market capitalisation, see Level Biotechnology market cap and net worth.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.49x | NT$-159.58 Million | NT$64.10 Million | NT$223.68 Million | ▼ -379.5% |
| 2023 | 0.89x | NT$62.54 Million | NT$70.21 Million | NT$7.67 Million | ▼ -0.6% |
| 2022 | 0.90x | NT$58.33 Million | NT$65.07 Million | NT$6.74 Million | ▼ -4.8% |
| 2021 | 0.94x | NT$146.79 Million | NT$155.95 Million | NT$9.15 Million | ▼ -2.9% |
| 2020 | 0.97x | NT$80.69 Million | NT$83.23 Million | NT$2.54 Million | ▼ -0.8% |
| 2019 | 0.98x | NT$106.60 Million | NT$109.02 Million | NT$2.43 Million | ▲ +7.9% |
| 2018 | 0.91x | NT$24.26 Million | NT$26.77 Million | NT$2.51 Million | ▲ +3.3% |
| 2017 | 0.88x | NT$62.55 Million | NT$71.29 Million | NT$10.83 Million | — |